These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32449087)
1. Proniosomal Microcarriers: Impact of Constituents on the Physicochemical Properties of Proniosomes as a New Approach to Enhance Inhalation Efficiency of Dry Powder Inhalers. Gamal A; Saeed H; Sayed OM; Kharshoum RM; Salem HF AAPS PharmSciTech; 2020 May; 21(5):156. PubMed ID: 32449087 [TBL] [Abstract][Full Text] [Related]
2. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate. Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847 [TBL] [Abstract][Full Text] [Related]
3. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance. Faulhammer E; Wahl V; Zellnitz S; Khinast JG; Paudel A Int J Pharm; 2015 Aug; 491(1-2):231-42. PubMed ID: 26136200 [TBL] [Abstract][Full Text] [Related]
4. The Relationship Between the Permeability and the Performance of Carrier-Based Dry Powder Inhalation Mixtures: New Insights and Practical Guidance. Shalash AO; Khalafallah NM; Molokhia AM; Elsayed MMA AAPS PharmSciTech; 2018 Feb; 19(2):912-922. PubMed ID: 29063377 [TBL] [Abstract][Full Text] [Related]
5. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content. Shalash AO; Molokhia AM; Elsayed MM Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831 [TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of insulin dry powder for inhalation. Mahesh Kumar T; Misra A Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123 [TBL] [Abstract][Full Text] [Related]
7. Performance tuning of particle engineered mannitol in dry powder inhalation formulations. Hertel N; Birk G; Scherließ R Int J Pharm; 2020 Aug; 586():119592. PubMed ID: 32622814 [TBL] [Abstract][Full Text] [Related]
8. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol. Kaialy W; Nokhodchi A Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318 [TBL] [Abstract][Full Text] [Related]
10. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections. Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Devrim B; Bozkır A; Canefe K Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727 [TBL] [Abstract][Full Text] [Related]
12. Dry Powder Inhalers Based on Chitosan-Mannitol Binary Carriers: Effect of the Powder Properties on the Aerosolization Performance. Zhao Z; Wang G; Huang Z; Huang Y; Chen H; Pan X; Zhang X AAPS PharmSciTech; 2022 Jun; 23(5):164. PubMed ID: 35697949 [TBL] [Abstract][Full Text] [Related]
13. Naringenin-Loaded Dipalmitoylphosphatidylcholine Phytosome Dry Powders for Inhaled Treatment of Acute Lung Injury. Yu Z; Liu X; Chen H; Zhu L J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):194-204. PubMed ID: 32176552 [No Abstract] [Full Text] [Related]
14. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose. Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921 [TBL] [Abstract][Full Text] [Related]
15. Exploring the potential influence of drug charge on downstream deposition behaviour of DPI powders. Sun Y; Cui Z; Sun Y; Qin L; Zhang X; Liu Q; Shen X; Yu D; Mao S Int J Pharm; 2020 Oct; 588():119798. PubMed ID: 32828976 [TBL] [Abstract][Full Text] [Related]
16. Particle engineered mannitol for carrier-based inhalation - A serious alternative? Hertel N; Birk G; Scherließ R Int J Pharm; 2020 Mar; 577():118901. PubMed ID: 31846726 [TBL] [Abstract][Full Text] [Related]
18. The effect of engineered mannitol-lactose mixture on dry powder inhaler performance. Kaialy W; Larhrib H; Martin GP; Nokhodchi A Pharm Res; 2012 Aug; 29(8):2139-56. PubMed ID: 22477070 [TBL] [Abstract][Full Text] [Related]
19. Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation. Moon C; Watts AB; Lu X; Su Y; Williams RO Mol Pharm; 2019 May; 16(5):1799-1812. PubMed ID: 30925839 [TBL] [Abstract][Full Text] [Related]
20. Effect of carrier particle shape on dry powder inhaler performance. Kaialy W; Alhalaweh A; Velaga SP; Nokhodchi A Int J Pharm; 2011 Dec; 421(1):12-23. PubMed ID: 21945739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]